Concepedia

Andreas Rühmann

AR

12

Publications

945

Citations

12

H-Index

1994

Active since

Affiliations

Max Planck Institute of Experimental Medicine(Current)

The University of Queensland

Australian Nuclear Science and Technology Organisation

Andreas Rühmann is an author at Max Planck Institute of Experimental Medicine specializing in medicine, biochemistry, and natural sciences.

Top concepts

Publications per year

1994–2009

12

Publications

12

Modulation of Learning and Anxiety by Corticotropin-Releasing Factor (CRF) and Stress: Differential Roles of CRF Receptors 1 and 2

Jelena Radulović, Andreas Rühmann, Thomas Liepold et al. · Journal of Neuroscience · 1999 · 406 citations · Full text

, , +25

Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): Development of CRFR2β-selective antisauvagine-30

Andreas Rühmann, Ines Bonk, Chijen R. Lin et al. · Proceedings of the National Academy of Sciences · 1998 · 174 citations

The highly selective CRF<sub>2</sub> receptor antagonist K41498 binds to presynaptic CRF<sub>2</sub> receptors in rat brain

Andrew J. Lawrence, Elena Krstew, Frank M. Dautzenberg et al. · British Journal of Pharmacology · 2002 · 73 citations · Full text

A synthetic glucagon-like peptide-1 analog with improved plasma stability

U. Ritzel, U. Leonhardt, M. Ottleben et al. · Journal of Endocrinology · 1998 · 60 citations · Full text

, , +13

Molecular Properties of the CRF Receptor

Joachim Spiess, Frank M. Dautzenberg, Sabine Sydow et al. · Trends in Endocrinology and Metabolism · 1998 · 47 citations

, , +9

Rows per page

1–5 of 12